                         SEQUENCE LISTING

<110>  Wake Forest University Health Sciences
       Debinski, Waldemar
       Gibo, Denise
 
<120>  ANTIBODIES AGAINST HUMAN AND CANINE IL-13RA2

<130>  9151-191WO

<150>  US 61/788,312
<151>  2013-03-15

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Artificial

<220>
<223>  Immunogenic peptide sequence

<400>  1

Thr Lys Asn Leu His Tyr Lys Asp Gly Phe Asp Leu Asn Lys Gly Ile 
1               5                   10                  15      


Glu Ala Lys Ile Cys 
            20      


<210>  2
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  Immunogenic peptide sequence

<400>  2

Ser Asp Asp Gly Ile Trp Ser Glu Trp Ser Asp Lys Gln Cys 
1               5                   10                  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Immunogenic peptide sequence

<400>  3

Ser Asp Tyr Lys Asp Phe Tyr Ile Cys Val Asn Gly Ser Ser Glu 
1               5                   10                  15  


<210>  4
<211>  26
<212>  DNA
<213>  Artificial

<220>
<223>  RT-PCR primer sequence

<400>  4
ttcattcatt tggatgtcgg attcct                                            26


<210>  5
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  RT-PCR primer sequence

<400>  5
cagggtccac tatctcaaaa tcct                                              24


<210>  6
<211>  16
<212>  DNA
<213>  Artificial

<220>
<223>  RT-PCR probe sequence

<400>  6
atgctgtgca aacaag                                                       16


<210>  7
<211>  327
<212>  DNA
<213>  Artificial

<220>
<223>  MAb 1E10B9 variable light chain DNA sequence

<400>  7
ccactcattt tgtcagttac cattggacaa ccagcctcta tctcttgcaa gtcaagtcag       60

agcgtcttat atagtaatgg aaaaacctat ttgaattggt tattacagag gccaggccag      120

tctccaaagc gcctaatcta tctggtgtct aaactggact ctggagtccc tgacaggttc      180

actggcagtg gatcaggaac agattttaca ttgaaaatca gcagagtgga ggctgaagat      240

ttgggagttt attactgcgt gcaaggttca cattttccgt acacgttcgg aggggggacc      300

aagctggaaa taaaacgggc tgatgct                                          327


<210>  8
<211>  116
<212>  PRT
<213>  Artificial

<220>
<223>  MAb 1E10B9 variable light chain protein sequence

<400>  8

Glu Ile Val Met Thr Gln Thr Pro Leu Ile Leu Ser Val Thr Ile Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Asn Gly Lys Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Val Gln Gly 
                85                  90                  95      


Ser His Phe Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg Ala Asp Ala 
        115     


<210>  9
<211>  324
<212>  DNA
<213>  Artificial

<220>
<223>  MAb 1E10B9 variable heavy chain DNA sequence

<400>  9
ggacctgagc tgaagaagcc tggagagaca gtcaagatct actgcaaggc ttctggttat       60

tccttcagag actattcagt gcactgggtg aaacaggctc caggaaaggg tttaaagtgg      120

atgggctgga taaatactga gactggtgaa ccaacatatg tggatgaatt caagggacga      180

tttgccttct ttttggaagc ctctgccaac actgtctatt tgcagatcag caacctcaaa      240

aatgaggaca cggctacata tttctgtgac taccgtttta cttactgggg ccaggggact      300

ctggtcactg tctctgcagc caaa                                             324


<210>  10
<211>  108
<212>  PRT
<213>  Artificial

<220>
<223>  MAb 1E10B9 variable heavy chain protein sequence

<400>  10

Gly Pro Glu Leu Lys Lys Pro Gly Glu Thr Val Lys Ile Tyr Cys Lys 
1               5                   10                  15      


Ala Ser Gly Tyr Ser Phe Arg Asp Tyr Ser Val His Trp Val Lys Gln 
            20                  25                  30          


Ala Pro Gly Lys Gly Leu Lys Trp Met Gly Trp Ile Asn Thr Glu Thr 
        35                  40                  45              


Gly Glu Pro Thr Tyr Val Asp Glu Phe Lys Gly Arg Phe Ala Phe Phe 
    50                  55                  60                  


Leu Glu Ala Ser Ala Asn Thr Val Tyr Leu Gln Ile Ser Asn Leu Lys 
65                  70                  75                  80  


Asn Glu Asp Thr Ala Thr Tyr Phe Cys Asp Tyr Arg Phe Thr Tyr Trp 
                85                  90                  95      


Gly Gln Gly Thr Leu Val Thr Val Ser Ala Ala Lys 
            100                 105             


